Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Exercices neurocognitifs pour l'instabilité de la cheville

8 novembre 2026 mis à jour par: Aysenur Erekdag, Istanbul University - Cerrahpasa

Un exercice enrichi sur le plan neurocognitif est-il efficace pour réduire le risque de nouvelle blessure et améliorer l'équilibre et la proprioception chez les personnes présentant une instabilité latérale de la cheville ?

In the general population, 19.0-26.6 per 1000 cases of ankle instability have been reported, while in the athletic population, the rate is 11.3 per 1000. Ankle instability also predisposes individuals to recurrent instability, leading to persistent symptoms. After ankle injuries, temporary increases in afferent activity, along with long-term deficits in somatosensory information from ligaments, may cause central neuroplasticity that affects sensorimotor function. This central neuroplasticity can lead to permanent dysfunctions in the affected limb, thereby increasing the likelihood of developing and maintaining chronic ankle instability (CAI). In addition to the association between impaired balance and reduced proprioception with CAI, it has been reported that the central nervous system may fail to manage joint stress due to its inability to discern load on the ligaments.

Impaired neurocognition has been linked to decreased performance and higher rates of re-injury. Deficiencies in neuromuscular control, motor learning, or other neurocognitive components related to an individual's performance and safety may affect the ability to respond appropriately in a dynamic environment. Any deficiencies in these neurocognitive processes can hinder the successful completion of tasks.

The aim of this study is to comparatively examine the effects of neurocognitively enriched rehabilitation versus traditional rehabilitation on re-injury risk, balance, and proprioception in individuals with a history of ankle instability.

Aperçu de l'étude

Description détaillée

Voluntary participants who have been diagnosed with lateral ankle instability will be included in the study. Signed voluntary consent will be obtained from participants. Participants will be divided into two groups. Study groups will be as follows: a) Neurocognitive Enriched Exercise, b) Multimodal Exercise.

Type d'étude

Interventionnel

Inscription (Estimé)

36

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

Lieux d'étude

      • Istanbul, Turquie (Türkiye)
        • Recrutement
        • Istanbul University-Cerrahpaşa
        • Sous-enquêteur:
          • Ipek Yeldan, Prof
        • Contact:
        • Sous-enquêteur:
          • Tekin Kerem Ulku, Assoc. Prof.
      • Istanbul, Turquie (Türkiye)
        • Recrutement
        • Acibadem Mehmet Ali Aydinlar University
        • Contact:
        • Chercheur principal:
          • Aysenur Erekdag, MSc
        • Sous-enquêteur:
          • Ipek Yeldan, Prof

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 55 ans (Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • The documented unilateral ankle instability confirmed through clinical examinations (drawer test, talar tilt test) and MRI in cases requiring differential diagnosis.
  • A history of an initial ankle sprain occurring at least 6 months ago.
  • The presence of a recurrent sense of giving way that started at least 6 months ago and has been intermittently persistent.

Exclusion Criteria:

  • Presence of a history of previous surgery in the lower extremity.
  • Identification of organic and non-organic lesions such as cartilage injuries, periarticular tendon tears, and impingement syndromes.
  • The existence of a fracture accompanying instability in the foot-ankle.
  • Presence of congenital deformities in the foot-ankle.
  • Diagnosis of talus osteochondral lesion.
  • Diagnosis of ankle arthritis.
  • Presence of medial ligament lesion.
  • Existence of peripheral neuropathy.
  • Presence of additional rheumatological diseases.
  • Regular moderate-level exercise for at least 3 days a week in the last 6 months.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Neurocognitive Enriched Exercise

Individuals with a diagnosis of lateral ankle instability who underwent supervised neurocognitive enriched exercise under the guidance of a physiotherapist for 8 weeks, 2 days a week.

An intervention planned, progressed, and conducted under the supervision of a physiotherapist, which enriches strengthening, balance, range of motion, stretching, and mobilization exercises with neurocognitive elements.

Comparateur actif: Multimodal Exercise

Individuals with a diagnosis of lateral ankle instability who underwent supervised routine exercise under the guidance of a physiotherapist for 8 weeks, 2 days a week.

Supervised and progressively advanced interventions that include strengthening, balance, range of motion, stretching, and mobilization exercises.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Cumberland Ankle Instability Tool (CAIT)
Délai: change from baseline at 6 months

It is a 30-point, 9-item scale measuring the severity of functional ankle instability. Lower scores indicate functional ankle instability. The Minimal Clinically Important Difference for this valid and reliable scale is 3 points.

change from baseline at 6 months
Surface Electromyography-maximum voluntary isometric contraction
Délai: change from baseline at 6 months

Electrode placements will be performed in accordance with the European Recommendations from Surface EMG for Non-Invasive Assessment of Muscles (SENIAM).

change from baseline at 6 months
Surface Electromyography-muscles' normal functional activities
Délai: change from baseline at 6 months

Electrode placements will be performed in accordance with the European Recommendations from Surface EMG for Non-Invasive Assessment of Muscles (SENIAM).

change from baseline at 6 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Ultrasonography
Délai: 3 times for 24 weeks

The pennation angles of the peroneal, gastrocnemius, and tibialis anterior muscle groups will be evaluated and recorded using ultrasonographic imaging. The pennation angle will be defined as the angle between the muscle fascicle and the superficial aponeurosis.

3 times for 24 weeks
Numeric Pain Rating Scale
Délai: 3 times for 24 weeks

Pain during activity in the ankle will be assessed with a pain NPRS, a numbered scale of 11 points. On this scale, "0" indicates no pain, and "10" indicates the most severe pain imaginable.

3 times for 24 weeks
Joint Range of Motion Evaluation
Délai: 3 times for 24 weeks

During the assessments, three repeat measurements will be made using an electronic goniometer. For goniometric measurement, the pivot point will be placed on the lateral malleolus. The fixed arm will be kept parallel to the lateral midline of the fibula. The moving arm, on the other hand, will follow the lateral midline of the 5th metatarsal bone.

3 times for 24 weeks
Tampa Kinesiophoby Scoring
Délai: 3 times for 24 weeks

It is a 17-item scale developed to assess the fear of movement/re-injury. The lowest possible score on the test is 17; the highest score is 68; and a score higher than 37 is an indicator of poor health outcomes.

3 times for 24 weeks
Star Excursion Test
Délai: 3 times for 24 weeks

Physical performance that requires strength, flexibility, and proprioception is assessed through a dynamic test evaluating dynamic postural control and lower extremity injury risk associated with musculoskeletal injuries. The protocol of the test involves maintaining balance on the ipsilateral leg while reaching as far as possible with the contralateral leg.

3 times for 24 weeks
Single Leg Stance Test
Délai: 3 times for 24 weeks

Participants' standing balance will be assessed. Initially, one foot will be positioned on a firm and flat surface with the entire lower extremity in full extension, while the other lower extremity is positioned with the hip and knee flexed at 90 degrees. With their eyes closed, participants will start the timing when the foot not being tested loses contact with the ground, and the timing will stop when they place their foot back on the ground or when there is a significant increase in body sway.

3 times for 24 weeks
The Side Hop Test
Délai: 3 times for 24 weeks

It is a test that assesses the functional stability of patients. Patients will be asked to stand on one leg on the affected extremity. They will then be required to perform 10 jumps over two pre-determined strips that are spaced 30 cm apart.

3 times for 24 weeks
Global Rating of Change Scale-GRC
Délai: 2 times for 52 weeks

It will be used to evaluate patient satisfaction. It is designed to determine the amount of improvement or worsening of the patient over time.

In our study, GRC consisting of 5 levels between -2 and +2 value ranges (-2: I am much worse, -1: I am worse, 0: I am the same, 1: I am better, 2: I am much better) was preferred.

2 times for 52 weeks
Reproduction Test
Délai: 3 times for 24 weeks

While the eyes of the individuals are closed, the ankle joints will be positioned and a goniometric measurement will be performed. Then, the patient will be brought to the starting position and asked to achieve the same movement. The difference between the two measurements will be recorded.

3 times for 24 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Ayşenur Erekdağ, MSc, Bezmialem Vakif University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

18 décembre 2025

Achèvement primaire (Estimé)

1 février 2027

Achèvement de l'étude (Estimé)

1 juin 2027

Dates d'inscription aux études

Première soumission

20 août 2024

Première soumission répondant aux critères de contrôle qualité

21 août 2024

Première publication (Réel)

23 août 2024

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

12 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

8 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2024_AE_Tez

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner